Crossmark Global Holdings’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-77,128
Closed -$3.56M – 1241
2025
Q3
$3.56M Buy
77,128
+50,482
+189% +$2.69M 0.05% 312
2025
Q2
$1.41M Buy
26,646
+5,463
+26% +$289K 0.02% 524
2025
Q1
$1.18M Buy
+21,183
New +$1.01M 0.02% 558
2024
Q2
– Sell
-3,646
Closed -$242K – 1304
2024
Q1
$242K Buy
3,646
+300
+9% +$24.4K ﹤0.01% 1197
2023
Q4
$329K Sell
3,346
-291
-8% -$25.3K 0.01% 1019
2023
Q3
$296K Buy
3,637
+70
+2% +$5.49K 0.01% 1020
2023
Q2
$298K Sell
3,567
-302
-8% -$28.2K 0.01% 1076
2023
Q1
$471K Buy
3,869
+245
+7% +$33.3K 0.01% 854
2022
Q4
$483K Sell
3,624
-244
-6% -$29.7K 0.01% 805
2022
Q3
$432K Sell
3,868
-10
-0.3% -$1.28K 0.01% 831
2022
Q2
$526K Sell
3,878
-180
-4% -$27.1K 0.01% 794
2022
Q1
$676K Buy
4,058
+90
+2% +$17.1K 0.02% 785
2021
Q4
$709K Buy
3,968
+640
+19% +$114K 0.02% 761
2021
Q3
$589K Hold
3,328
– – 0.01% 841
2021
Q2
$535K Buy
3,328
+2
+0.1% +$308 0.01% 883
2021
Q1
$498K Sell
3,326
-10
-0.3% -$1.21K 0.01% 902
2020
Q4
$329K Buy
+3,336
New +$333K 0.01% 1044

Other funds holding CNXC

Crossmark Global Holdings's CNXC Position: Q4 2025 in Review

Crossmark Global Holdings sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 77,128 shares — an estimated $3.56M sold.

Crossmark Global Holdings first reported a position in CNXC in Q4 2020 and held it in 17 quarters. The position peaked at $3.56M in Q3 2025. 337 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Crossmark Global Holdings reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Crossmark Global Holdings sold 77,128 Concentrix shares in Q4 2025, an estimated $3.56M.
  • Crossmark Global Holdings first reported a position in Concentrix in Q4 2020 and held it in 17 quarters.
  • Crossmark Global Holdings's Concentrix position peaked at $3.56M in Q3 2025.
  • 337 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Crossmark Global Holdings's 13F filing for Q4 2025, filed 3 Feb 2026.